The hormonal Intra Uterine Device (HIUD) is a highly effective intrauterine contraceptive device that gives pregnancy protection for five years. The national family planning (FP) program has been using the copper Intra Uterine Device (IUD) for decades, but has not been successful in increasing its use rate. The National Technical Committee (NTC) and the Directorate General of Family Planning (DGFP) advised conducting a pilot study to assess acceptability and feasibility of introducing the HIUD in public sector facilities in 2020, which was approved by the Bangladesh Medical Research Council (BMRC). from January 2022 to October 2023, the Clinical Contraception Services Delivery Program (CCSDP) and DGFP implemented a 24-month prospective cohort study with support from the USAID Shukhi Jibon project, Pathfinder, and the Population Council in seven high-volume facilities under DGFP, Directorate General of Health Services (DGHS), and the private sector. The objectives were to assess the feasibility of introducing the HIUD in the public sector’s facilities, the acceptability of this method (from the perspective of both providers and clients), and the level of clients’ satisfaction with the HIUD. This report contains the salient findings from the study.
Publications